Ultragenyx (RARE) Down 5.7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/05/19
Ultragenyx Pharmaceutical Inc.'s (RARE) CEO Emil Kakkis on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/07/19